A CRISPR-dCas13 RNA-editing tool to study alternative splicing

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Alternative splicing generates diverse proteins from a single gene, impacting biological processes and diseases.
• The precise roles of splicing isoforms and their regulatory elements are challenging to study.
• Limitations in current methods hinder the investigation of alternative splicing's significance.

Purpose of the Study:

• To develop a cost-effective method for switching alternative splicing patterns of endogenous transcripts.
• To identify key regulatory RNA elements controlling specific splicing events.
• To expand the RNA toolkit for understanding alternative splicing mechanisms and physiological impacts.

Main Methods:

• Utilized dCasRx, a catalytically inactive RNA-targeting CRISPR-dCas13 ortholog.
• Applied the dCasRx system to efficiently switch alternative splicing patterns.
• Demonstrated a new application for identifying regulatory RNA elements.

Main Results:

• Successfully switched alternative splicing patterns of endogenous transcripts using dCasRx.
• Achieved this without altering overall gene expression levels.
• Validated the dCasRx system's utility in identifying key regulatory RNA elements for splicing events.

Conclusions:

• dCasRx offers a powerful and cost-effective approach to manipulate alternative splicing.
• This splice-editing system facilitates the identification of critical RNA regulatory elements.
• The expanded RNA toolkit enhances the understanding of alternative splicing in health and disease.